# Effects of a Nutraceutic Compound on Cognitive Impairment

> **NCT06200883** · PHASE4 · COMPLETED · sponsor: **Federico II University** · enrollment: 58 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Placebo oral vial
- **DRUG:** Choline Bitartrate

## Key facts

- **NCT ID:** NCT06200883
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200883, "Effects of a Nutraceutic Compound on Cognitive Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06200883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*